Coagulation and heparin requirements during ablation in patients under oral anticoagulant drugs.
Philippe MaurySlimane BelaidAgnès RibesQuentin Voglimacci-StephanopoliPierre MondolyMarie BlayeFranck MandelBenjamin MonteilDidier CarriéMichel GalinierVanina BongardAnne RollinSophie VoisinPublished in: Journal of arrhythmia (2020)
Vitamin K antagonists allowed less heparin requirement despite reaching higher ACT values and more efficient anticoagulation control (with more excessive values) compared to patients under DOAC therapy and to controls. There was no difference in heparin requirements or ACT between DOAC patients and controls.